{'fraction_non_alphanumeric': 0.020793950850661626, 'fraction_numerical': 0.0, 'mean_word_length': 5.883116883116883, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Retinopathy of prematurity

Purpose of review This review highlights recent advances in basic science and clinical research on retinopathy of prematurity (ROP). Recent findings The modern concept of ROP pathophysiology is discussed, as are studies investigating anti-angiogenic agents for treatment. Results of the largest clinical trials are summarized. Current screening criteria, potential modifications to them, and telephotoscreening are discussed. Summary ROP is a challenging and involving area of pediatric ophthalmology.